发明申请
US20070010539A1 SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES
失效
取代的8'-哌嗪(MI)十二烷基二 - [环己基] - 吡咯并[1,2-a]吡啶-6-酮衍生物
- 专利标题: SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES
- 专利标题(中): 取代的8'-哌嗪(MI)十二烷基二 - [环己基] - 吡咯并[1,2-a]吡啶-6-酮衍生物
-
申请号: US11423557申请日: 2006-06-12
-
公开(公告)号: US20070010539A1公开(公告)日: 2007-01-11
- 发明人: Nathalie CHEREZE , Alistair LOCHEAD , Mourad SAADY , Franck SLOWINSKI , Philippe YAICHE
- 申请人: Nathalie CHEREZE , Alistair LOCHEAD , Mourad SAADY , Franck SLOWINSKI , Philippe YAICHE
- 申请人地址: FR Paris JP Osaka
- 专利权人: SANOFI-AVENTIS,MITSUBISHI PHARMA CORPORATION
- 当前专利权人: SANOFI-AVENTIS,MITSUBISHI PHARMA CORPORATION
- 当前专利权人地址: FR Paris JP Osaka
- 优先权: EP03293236.0 20031219
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; C07D487/14
摘要:
The invention relates to a dihydrospiro-[cycloalkylamine]-pyrimidone derivative represented by formula (I) or a salt thereof: wherein X, Y, R1, R2, R3, R4, o, m, n, p and q are as defined herein. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β, such as Alzheimer disease.
公开/授权文献
信息查询
IPC分类: